Femara 2.5 mg (Letrozole TABLET) 2.5 MG

Femara 2.5 mg tablets contain letrozole, a medication used to manage certain conditions related to hormone levels. This oral tablet is commonly prescribed for its therapeutic effects in hormone-sensitive conditions.

Strength

2.5 MG

Pack Size

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Femara 2.5 mg tablets are primarily used to manage conditions influenced by hormone levels, particularly in postmenopausal women. Letrozole works by reducing estrogen production, which can be beneficial in certain therapeutic contexts. It is often prescribed for conditions where hormone regulation is crucial.

Side Effects

Common effects of Femara 2.5 mg tablets may include changes in hormone levels, which can lead to various physiological responses. Some individuals may experience symptoms such as hot flashes, fatigue, or joint pain. These effects can vary widely among users.

Precautions & Warnings

Femara 2.5 mg tablets should be handled with care, especially by individuals with pre-existing medical conditions. It is important to follow the guidance of a healthcare provider regarding administration and monitoring. Regular check-ups may be recommended to assess the body's response to the medication.

Avoid Interactions

Femara 2.5 mg tablets may interact with certain substances, including alcohol and other medications. It is advisable to inform a healthcare provider about all current medications and lifestyle factors to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

Femara 2.5 mg tablets are used to manage conditions influenced by hormone levels, particularly in postmenopausal women.

Femara 2.5 mg tablets are taken orally, typically as directed by a healthcare provider.

Common effects may include hot flashes, fatigue, and joint pain, though individual experiences can vary.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safety.

Individuals with pre-existing medical conditions should consult a healthcare provider before using Femara 2.5 mg tablets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.